HIV infection and stroke: Current perspectives and future directions

The Lancet Neurology

Volumn 11, Issue 10, 2012, Pages 878-890

  Benjamin, Laura A ^a,b,c   Bryer, Alan ^d   Emsley, Hedley C A ^e,f   Khoo, Saye ^a   Solomon, Tom ^a,c   Connor, Myles D ^g,h,i  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^c THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e ROYAL PRESTON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g NHS FIFE   (United Kingdom)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR;

ANTIVIRAL THERAPY; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOPSY; BLOOD CLOTTING DISORDER; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STROKE; VASCULAR DISEASE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; STROKE;

EID: 84866447961     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70205-3     Document Type: Review

References (120)

1. Feigin VL, Lawes CMM, Bennett DA, Barker-Collo SL, Parag V Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8:355-369.
2. Feigin VL Stroke in developing countries: can the epidemic be stopped and outcomes improved?. Lancet Neurol 2007, 6:94-97.
3. Walker R, Whiting D, Unwin N, et al. Stroke incidence in rural and urban Tanzania: a prospective, community-based study. Lancet Neurol 2010, 9:786-792.
4. Emsley HCA, Hopkins SJ Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008, 7:341-353.
5. Quinn TC Global burden of the HIV pandemic. Lancet 1996, 348:99-106.
6. Dobbs MR, Berger JR Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther 2009, 7:1263-1271.
7. Sen S, Rabinstein AA, Elkind MS, Powers WJ Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc Dis 2012, 33:209-218.
8. Kieburtz KD, Eskin TA, Ketonen L, Tuite MJ Opportunistic cerebral vasculopathy and stroke in patients with the acquired immunodeficiency syndrome. Arch Neurol 1993, 50:430-432.
9. Moskowitz LB, Hensley GT, Chan JC, Gregorios J, Conley FK The neuropathology of acquired immune deficiency syndrome. Arch Pathol Lab Med 1984, 108:867-872.
10. Sharer LR, Kapila R Neuropathologic observations in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol 1985, 66:188-198.
11. Mizusawa H, Hirano A, Llena JF, Shintaku M Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1988, 76:451-457.
12. Berger JR, Harris JO, Gregorios J, Norenberg M Cerebrovascular disease in AIDS: a case-control study. AIDS 1990, 4:239-244.
13. Connor MD, Lammie GA, Bell JE, Warlow CP, Simmonds P, Brettle RD Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 2000, 31:2117-2126.
14. Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV The neuropathology of AIDS. UCLA experience and review. Am J Pathol 1986, 124:537-558.
15. Pinto AN AIDS/HIV infection and cerebrovascular disease. Semin Cerebrovasc Dis Stroke 2005, 5:6.
16. Ovbiagele B, Nath A Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 2011, 76:444-450.
17. Berger JR AIDS and stroke risk. Lancet Neurol 2004, 3:206-207.
18. de Gaetano Donati K, Rabagliati R, Iacoviello L, Cauda R HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis 2004, 4:213-222.
19. Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg 2011, 105:644-649.
20. Emsley HC, Tyrrell PJ Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002, 22:1399-1419.
21. Lindsberg PJ, Grau AJ Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34:2518-2532.
22. Qureshi AI HIV infection and stroke: if not protein S deficiency then what explains the relationship?. J Neurol Neurosurg Psychiatr 2005, 76:1331.
23. Cole JW, Pinto AN, Hebel JR, et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004, 35:51-56.
24. Hoffmann M, Berger JR, Nath A, Rayens M Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J Neurovirol 2000, 6:229-236.
25. Hoffman MW. The Durban Stroke Data Bank with special emphasis on higher cortical function deficits. MD thesis, University of Natal, 1998.
26. Patel VB, Sacoor Z, Francis P, Bill PL, Bhigjee AI, Connolly C Ischemic stroke in young HIV-positive patients in Kwazulu-Natal, South Africa. Neurology 2005, 65:759-761.
27. Rasmussen LD, Engsig FN, Christensen H, et al. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. AIDS 2011, 25:1637-1646.
28. Ortiz G, Koch S, Romano JG, Forteza AM, Rabinstein AA Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007, 68:1257-1261.
29. Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatr 2007, 78:1320-1324.
30. Heikinheimo T, Chimbayo D, Kumwenda JJ, Kampondeni S, Allain TJ Stroke outcomes in Malawi, a country with high prevalence of HIV: a prospective follow-up study. PLoS One 2012, 7:e33765.
31. Kumwenda JJ, Mateyu G, Kampondeni S, van Dam AP, van Lieshout L, Zijlstra EE Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke 2005, 36:960-964.
32. Bermel C, Spuntrup E, Fink G, Nowak DA Stroke in an adult with HIV infection due to carotid artery stenosis successfully treated with steroids: HIV-associated arteritis?. J Neurol 2009, 256:1563-1565.
33. Tipping B, de Villiers L, Candy S, Wainwright H Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol 2006, 63:1640-1642.
34. Sharfstein SR, Ahmed S, Islam MQ, Najjar MI, Ratushny V Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome. J Stroke Cerebrovasc Dis 2007, 16:268-272.
35. Melica G, Brugieres P, Lascaux AS, Levy Y, Lelievre JD Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J Med Virol 2009, 81:578-581.
36. Bhagavati S, Choi J Rapidly progressive cerebrovascular stenosis and recurrent strokes followed by improvement in HIV vasculopathy. Cerebrovasc Dis 2008, 26:449-452.
37. Mochan A, Modi M, Modi G Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J Neurol Neurosurg Psychiatr 2005, 76:1455-1456.
38. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
39. Morris JG, Singh S, Fisher M Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?. Stroke 2010, 41:2985-2990.
40. Kenet G, Lutkhoff LK, Albisetti M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010, 121:1838-1847.
41. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
42. Mochan A, Modi M, Modi G Stroke in black South African HIV-positive patients: a prospective analysis. Stroke 2003, 34:10-15.
43. Giannakopoulos B, Passam F, Ioannou Y, Krilis SA How we diagnose the antiphospholipid syndrome. Blood 2009, 113:985-994.
44. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J 2012, 33:866-874.
45. Magula NP, Mayosi BM Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovasc J S Afr 2003, 14:231-237.
46. Ntsekhe M, Mayosi BM Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 2009, 6:120-127.
47. Ntusi NB, Mayosi BM Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther 2009, 7:169-180.
48. Barbaro G Cardiovascular manifestations of HIV infection. Circulation 2002, 106:1420-1425.
49. Barbaro G, Fisher SD, Lipshultz SE Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis 2001, 1:115-124.
50. Lammie GA, Hewlett RH, Schoeman JF, Donald PR Tuberculous cerebrovascular disease: a review. J Infect 2009, 59:156-166.
51. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009, 8:731-740.
52. Timmermans M, Carr J Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatr 2004, 75:1727-1730.
53. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992, 326:668-672.
54. Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008, 70:853-860.
55. Gutierrez J, Ortiz G HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series. Clin Neuroradiol 2011, 21:145-151.
56. Zetola NM, Engelman J, Jensen TP, Klausner JD Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin Proc 2007, 82:1091-1102.
57. Chahine LM, Khoriaty RN, Tomford WJ, Hussain MS The changing face of neurosyphilis. Int J Stroke 2011, 6:136-143.
58. Anderson AM, Fountain JA, Green SB, Bloom SA, Palmore MP Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution. J Neurovirol 2010, 16:179-184.
59. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009, 48:e96-107.
60. Lucas SB, Curtis H, Johnson MA National review of deaths among HIV-infected adults. Clin Med 2008, 8:250-252.
61. Newsome SD, Nath A Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009, 15:288-291.
62. Chetty R, Batitang S, Nair R Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000, 31:374-379.
63. Nair R, Abdool-Carrim A, Chetty R, Robbs J Arterial aneurysms in patients infected with human immunodeficiency virus: a distinct clinicopathology entity?. J Vasc Surg 1999, 29:600-607.
64. Modi G, Ranchod K, Modi M, Mochan A Human immunodeficiency virus associated intracranial aneurysms: report of three adult patients with an overview of the literature. J Neurol Neurosurg Psychiatr 2008, 79:44-46.
65. Chetty R Vasculitides associated with HIV infection. J Clin Pathol 2001, 54:275-278.
66. Bulsara KR, Raja A, Owen J HIV and cerebral aneurysms. Neurosurg Rev 2005, 28:92-95.
67. Mazzoni P, Chiriboga CA, Millar WS, Rogers A Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review. Pediatr Neurol 2000, 23:252-255.
68. Nogueras C, Sala M, Sasal M, et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch Neurol 2002, 59:468-473.
69. Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 1993, 36:1164-1174.
70. Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J HIV infection and atherosclerosis: evaluating the drivers of inflammation. Eur J Prev Cardiol 2012, published online May 3. 10.1177/2047487312447843.
71. Micheloud D, Berenguer J, Guzman-Fulgencio M, et al. European mitochondrial DNA haplogroups and metabolic disorders in HIV/HCV-coinfected patients on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2011, 58:371-378.
72. Elkind MS, Luna JM, Moon YP, et al. Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke 2010, 41:e117-e122.
73. Chi D, Henry J, Kelley J, Thorpe R, Smith JK, Krishnaswamy G The effects of HIV infection on endothelial function. Endothelium 2000, 7:223-242.
74. Tinkle BT, Ngo L, Luciw PA, Maciag T, Jay G Human immunodeficiency virus-associated vasculopathy in transgenic mice. J Virol 1997, 71:4809-4814.
75. Hag AM, Kristoffersen US, Pedersen SF, Gutte H, Lebech AM, Kjaer A Regional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats. PLoS One 2009, 4:e8170.
76. Abi F, el Fares F, el Moussaoui A, Laaroussi H, Touzani K, Zerouali N Caustic lesions of the upper digestive tract. Apropos of 191 cases. J Chir (Paris) 1986, 123:390-394. (in French).
77. Kline ER, Sutliff RL The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med 2008, 56:752-769.
78. Lo J, Plutzky J The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients. J Infect Dis 2012, 205(suppl 3):S368-S374.
79. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5:e203.
80. Eugenin EA, Morgello S, Klotman ME, et al. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol 2008, 172:1100-1111.
81. Park IW, Wang JF, Groopman JE HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood 2001, 97:352-358.
82. Floris-Moore M, Fayad ZA, Berman JW, et al. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS 2009, 23:941-949.
83. Ross AC, Rizk N, O'Riordan MA, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis 2009, 49:1119-1127.
84. Schved JF, Gris JC, Arnaud A, et al. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator. J Lab Clin Med 1992, 120:411-419.
85. Neuhaus J, Jacobs DR, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010, 201:1788-1795.
86. Triant VA, Grinspoon SK Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care. J Infect Dis 2011, 203:439-441.
87. Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011, 204:1227-1236.
88. Westhorpe CL, Zhou J, Webster NL, et al. Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages. J LeGBRoc Biol 2009, 85:1027-1035.
89. Schecter AD, Berman AB, Yi L, et al. HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci USA 2001, 98:10142-10147.
90. Clark S, Duggan J, Chakraborty J Tsl and LP-BM5: a comparison of two murine retrovirus models for HIV. Viral Immunol 2001, 14:95-109.
91. Baliga RS, Chaves AA, Jing L, Ayers LW, Bauer JA AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS. Am J Physiol Heart Circ Physiol 2005, 289:H1373-H1380.
92. Oliviero U, Bonadies G, Apuzzi V, et al. Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis 2009, 204:586-589.
93. Solages A, Vita JA, Thornton DJ, et al. Endothelial function in HIV-infected persons. Clin Infect Dis 2006, 42:1325-1332.
94. Seaberg EC, Benning L, Sharrett AR, et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke 2010, 41:2163-2170.
95. Baker JV, Henry WK, Patel P, et al. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis 2011, 53:826-835.
96. Gutierrez J, Glenn M, Isaacson RS, Marr AD, Mash D, Petito C Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: a pilot study. Stroke 2012, 43:1156-1158.
97. de Gaetano Donati K, Rabagliati R, Tumbarello M, et al. Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. AIDS 2003, 17:765-768.
98. Corral I, Quereda C, Moreno A, et al. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc Dis 2009, 27:559-563.
99. Cruciani M, Zanichelli V, Serpelloni G, et al. Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data. AIDS 2011, 25:1993-2004.
100. Boccara F, Cohen A Coronary artery disease and stroke in HIV-infected patients: prevention and pharmacological therapy. Adv Cardiol 2003, 40:163-184.
101. Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM Tuberculous meningitis: a 30-year review. Clin Infect Dis 1993, 17:987-994.
102. Nelson CA, Zunt JR Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis 2011, 53:915-926.
103. Marra CM, Tantalo LC, Maxwell CL, Dougherty K, Wood B Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004, 63:85-88.
104. Cornely OA, Hauschild S, Weise C, et al. Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection. Infection 1999, 27:92-96.
105. Savige JA, Chang L, Crowe SM Anti-neutrophil cytoplasm antibodies in HIV infection. Adv Exp Med Biol 1993, 336:349-352.
106. Jansen TL, van Houte D, de Vries T, Wolthuis A ANCA seropositivity in HIV: a serological pitfall. Neth J Med 2005, 63:270-274.
107. Bryer A, Connor MD, Haug P, et al. The South African guideline for the management of ischemic stroke and transient ischemic attack: recommendations for a resource-constrained health care setting. Int J Stroke 2011, 6:349-354.
108. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003, 348:702-710.
109. Bozzette SA HIV and cardiovascular disease. Clin Infect Dis 2011, 53:92-93.
110. Bedimo RJ, Westfall AO, Drechsler H, Vidiella G, Tebas P Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clin Infect Dis 2011, 53:84-91.
111. Currier JS, Lundgren JD, Carr A, et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008, 118:e29-e35.
112. Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002, 360:1747-1748.
113. Kwong GP, Ghani AC, Rode RA, et al. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. AIDS 2006, 20:1941-1950.
114. Islam F, Wu J, Jansson J, Wilson D Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med 2012, published online Mar 14. 10.1111/j.1468-1293.2012.00996.x.
115. Wamai RG, Morris BJ, Bailis SA, et al. Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. J Int AIDS Soc 2011, 14:49.
116. Ocama P, Seremba E Management of HIV and hepatitis C virus infections in resource-limited settings. Curr Opin HIV AIDS 2011, 6:539-545.
117. Warlow C, van Gijn J, Dennis M, et al. Stroke: practical management 2008, Blackwell Publishing, Malden, MA.
118. Shurtleff D, Lawrence D HIV and substance abuse: a commentary. Curr HIV Res 2012, published online May 10, (accessed July 20, 2012). http://benthamscience.com/epub.php?JCode=CHR.
119. Benjamin LA, Lewthwaite P, Vasanthapuram R, et al. Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis 2011, 17:1484-1487.
120. Hatano S Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976, 54:541-553.